CD274 and non-small cell lung carcinoma: Therefore, in this systematic review and meta-analysis of randomized controlled trials (RCTs), we aim to clarify the efficacy and safety of using neoadjuvant or adjuvant PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone in resectable stage (I-III) NSCLC.